Maze Therapeutics, Inc.
USD29.30
+0.93 (+3.28%)
CEO
Jason Coloma
IPO Date
2025-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$28.50
Prev. Close
$28.37
Day Low
$28.50
Day High
$29.54
52W Low
$12.81
52W High
$53.65
Market Cap
$1.62B
Volume
0.37M
| 13,409 |
| $29.86 |
| 2 Jul 2026 | Bernstein Harold | President, R&D & CMO | S-Sale | Disposed | 1,200 | $30.34 |
| 2 Jul 2026 | Bernstein Harold | President, R&D & CMO | M-Exempt | Disposed | 14,609 | $10.42 |
| 2 Jul 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 2,593 | $29.98 |
| 2 Jul 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 30,311 | $29.95 |
| 2 Jul 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 1,597 | $30.44 |
| 1 Jul 2026 | Dandekar Atul | CSBO | M-Exempt | Acquired | 7,500 | $10.42 |
| 1 Jul 2026 | Dandekar Atul | CSBO | S-Sale | Disposed | 7,500 | $28.02 |
| 1 Jul 2026 | Dandekar Atul | CSBO | M-Exempt | Disposed | 7,500 | $10.42 |